Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bang, O. Y.
Right arrow Articles by Huh, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bang, O. Y.
Right arrow Articles by Huh, K.
Related Collections
Right arrow Endocrine
Right arrow All Cerebrovascular disease/Stroke
Right arrow All epidemiology
Right arrow Risk factors in epidemiology
Right arrow Infarction
Right arrowRelated Articles
NEUROLOGY 2005;65:296-298
© 2005 American Academy of Neurology


Brief Communications

Association of the metabolic syndrome with intracranial atherosclerotic stroke

O. Y. Bang, MD, PhD, J. W. Kim, MD, J. H. Lee, MD, M. A. Lee, MD, P. H. Lee, MD, PhD, I. S. Joo, MD and K. Huh, MD

From the Department of Neurology, School of Medicine, Ajou University, Suwon, South Korea.

Address correspondence and reprint requests to Dr. Oh Young Bang, Department of Neurology, School of Medicine, Ajou University, Woncheon-dong San 5, Paldal-ku, Suwon, Kyungki-do, 442-749, South Korea; e-mail: nmboy{at}unitel.co.kr

To investigate the impact of metabolic syndrome (MetSD) on the development of intracranial atherosclerotic stroke, the authors evaluated the components of the MetSD in 512 patients with stroke. The MetSD was observed most frequently in patients with intracranial atherosclerosis (p = 0.007). In multiple regression analysis, the MetSD, but not conventional risk factors, was independently associated with intracranial atherosclerosis (p = 0.005). The results suggest that treatment of metabolic abnormalities may be an important prevention strategy for intracranial atherosclerosis.


Editorial, see page 188

Supported by Korea Research Foundation grant KRF-2003-E00228.

Received November 4, 2004. Accepted in final form March 30, 2005.


Related Articles

July 26 Highlights
Neurology 2005 65: 184-185. [Full Text] [PDF]

Metabolic syndrome and intracranial atherosclerosis: A new link?
Cheryl D. Bushnell and David Guzick
Neurology 2005 65: 188-189. [Full Text] [PDF]



This article has been cited by other articles:


Home page
StrokeHome page
B. L. Man, Y. P. Fu, Y. Y. Chan, W. Lam, A. C. F. Hui, W. H. Leung, V. Mok, and K. S. Wong
Lesion Patterns and Stroke Mechanisms in Concurrent Atherosclerosis of Intracranial and Extracranial Vessels
Stroke, October 1, 2009; 40(10): 3211 - 3215.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. B. Gorelick, K. S. Wong, H.-J. Bae, and D. K. Pandey
Large Artery Intracranial Occlusive Disease: A Large Worldwide Burden but a Relatively Neglected Frontier
Stroke, August 1, 2008; 39(8): 2396 - 2399.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
K. Park, N. Yasuda, S. Toyonaga, S. M. Yamada, H. Nakabayashi, M. Nakasato, T. Nakagomi, E. Tsubosaki, and K. Shimizu
Significant association between leukoaraiosis and metabolic syndrome in healthy subjects
Neurology, September 4, 2007; 69(10): 974 - 978.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. F. Arenillas, M. A. Moro, and A. Davalos
The Metabolic Syndrome and Stroke: Potential Treatment Approaches
Stroke, July 1, 2007; 38(7): 2196 - 2203.
[Full Text] [PDF]


Home page
NeurologyHome page
K. S. Wong, P. W. Ng, A. Tang, R. Liu, V. Yeung, and B. Tomlinson
Prevalence of asymptomatic intracranial atherosclerosis in high-risk patients
Neurology, June 5, 2007; 68(23): 2035 - 2038.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
O. Y. Bang, J. L. Saver, B. Ovbiagele, Y. J. Choi, S. R. Yoon, and K. H. Lee
Adiponectin levels in patients with intracranial atherosclerosis
Neurology, May 29, 2007; 68(22): 1931 - 1937.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
B. Ovbiagele, J. L. Saver, M. J. Lynn, M. Chimowitz, and for the WASID Study Group
Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis
Neurology, May 9, 2006; 66(9): 1344 - 1349.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
B. Ovbiagele and O. Y. Bang
Association of the metabolic syndrome with intracranial atherosclerotic stroke
Neurology, February 14, 2006; 66(3): 459 - 459.
[Full Text] [PDF]


Home page
NeurologyHome page
C. D. Bushnell and D. Guzick
Metabolic syndrome and intracranial atherosclerosis: A new link?
Neurology, July 26, 2005; 65(2): 188 - 189.
[Full Text] [PDF]

Correspondence:

Read all Correspondence

Association of the metabolic syndrome with intracranial atherosclerotic stroke
Bruce Ovbiagele
Neurology Online, 22 Aug 2005 [Full text]
Reply to Ovbiagele
Oh Young Bang
Neurology Online, 22 Aug 2005 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by AAN Enterprises, Inc.